Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery
about
MRS-based Metabolomics in Cancer Research.1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.Metabolic characterization of triple negative breast cancer.Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesAssessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR MetabolomicsRecent advances in metabolomics in neurological disease, and future perspectives.Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review.Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.Metabolic Footprints and Molecular Subtypes in Breast Cancer.Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles.Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles.Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours.Metabolomics research on potential role for 9-cis-retinoic acid in breast cancer progression.
P2860
Q30842175-F41CA47A-1C9B-4524-B440-5FA7ABDD04BFQ33921319-3B7B73CC-9DE6-4088-94F1-314A7FCA25DEQ34967995-BA44719D-B822-471E-852A-1C694972FF57Q36514020-836D610E-01B0-499C-959F-E61717148341Q37040438-0FF4094D-3477-43BB-90DA-8784301FD44FQ37465431-F5129E40-7620-4131-AC97-291EE992B02AQ38110171-DE77B453-F92E-41CA-A534-822062DCF727Q38936269-E59FFCB9-CBB3-45E3-9F3D-5C2E2C9BDAB9Q41009514-E58250B5-9858-4339-AAF5-A111E27806C2Q41369888-A6725D68-F7DC-499C-A107-828933D67DC1Q47703403-E36C68C9-DE96-4DDA-BD27-E8CEBDF3E654Q48338205-E1B518F3-CF57-4615-8397-0D296CC242C3Q49871101-1519A6CD-310B-4B54-8D14-7FAF6B5F4FD8Q49979397-AB159CD0-08DF-4C44-8961-C6EC72353C5BQ52597601-A4E57240-F422-43EA-82B0-EC80C2E4DDCCQ52655039-86DDEEC1-5A22-4B3E-8F88-AC765F26365DQ54935926-567BCD15-DFC7-44FB-B713-4A4D8D4B43C0Q55518177-320391CF-D412-407F-8531-87E207709202
P2860
Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Feasibility of MR metabolomics ...... s during breast cancer surgery
@ast
Feasibility of MR metabolomics ...... s during breast cancer surgery
@en
Feasibility of MR metabolomics ...... s during breast cancer surgery
@nl
type
label
Feasibility of MR metabolomics ...... s during breast cancer surgery
@ast
Feasibility of MR metabolomics ...... s during breast cancer surgery
@en
Feasibility of MR metabolomics ...... s during breast cancer surgery
@nl
prefLabel
Feasibility of MR metabolomics ...... s during breast cancer surgery
@ast
Feasibility of MR metabolomics ...... s during breast cancer surgery
@en
Feasibility of MR metabolomics ...... s during breast cancer surgery
@nl
P2093
P2860
P50
P1433
P1476
Feasibility of MR metabolomics ...... s during breast cancer surgery
@en
P2093
Brigitte Geurts
Geert Postma
Guro F Giskeødegård
Hans E Fjøsne
Lutgarde M Buydens
P2860
P304
P356
10.1371/JOURNAL.PONE.0061578
P407
P577
2013-04-17T00:00:00Z